GlobeNewswire: Marrone Bio Innovations Contains the last 10 of 284 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T13:45:06ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/07/11/2477279/0/en/Marrone-Bio-Innovations-Inc-Shareholders-Approve-Merger-Agreement-with-Bioceres-Crop-Solutions-Corp.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.2022-07-11T12:30:00Z<![CDATA[RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI’s stockholders approved the adoption of the Merger Agreement and approved on a non-binding advisory basis certain executive compensation that may be paid or become payable in connection with the merger contemplated by the Merger Agreement. The final voting results for each proposal voted on at the special meeting will be set forth in a Form 8-K filed by MBI with the U.S. Securities and Exchange Commission.]]>https://www.globenewswire.com/news-release/2022/05/11/2441221/0/en/Marrone-Bio-Innovations-Inc-Reports-First-Quarter-2022-Financial-Results.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results2022-05-11T20:01:00Z<![CDATA[RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include:]]>https://www.globenewswire.com/news-release/2022/04/27/2430184/0/en/Marrone-Bio-Innovations-to-Report-First-Quarter-2022-Results-on-Wednesday-May-11-at-4-30-p-m-Eastern-Time.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time2022-04-27T12:00:00Z<![CDATA[RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022.]]>https://www.globenewswire.com/news-release/2022/03/28/2411364/0/en/Marrone-Bio-Innovations-Inc-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results2022-03-28T20:01:00Z<![CDATA[RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include:]]>https://www.globenewswire.com/news-release/2022/03/24/2409471/0/en/Marrone-Bio-Expands-Biological-Seed-Treatment-Collaboration-for-Row-Crops.html?f=22&fvtc=4&fvtv=19271Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops2022-03-24T13:00:00Z<![CDATA[Company poised for continued growth in a $6+ billion market¹ Company poised for continued growth in a $6+ billion market¹]]>https://www.globenewswire.com/news-release/2022/03/16/2404848/0/en/Bioceres-Crop-Solutions-and-Marrone-Bio-Announce-Merger-Agreement.html?f=22&fvtc=4&fvtv=19271Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement2022-03-16T21:30:49Z<![CDATA[Combined company creates global leader in sustainable agricultural solutions]]>https://www.globenewswire.com/news-release/2022/03/08/2398837/0/en/Marrone-Bio-Innovations-to-Report-Fourth-Quarter-and-Full-Year-2021-Results-on-Monday-March-28-at-4-30-p-m-Eastern-Time.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time2022-03-08T13:00:00Z<![CDATA[RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the fourth quarter and full year ended December 31, 2021, after market close on Monday, March 28, 2022.]]>https://www.globenewswire.com/news-release/2022/02/22/2389838/0/en/Marrone-Bio-Announces-CFO-Transition.html?f=22&fvtc=4&fvtv=19271Marrone Bio Announces CFO Transition2022-02-22T21:30:00Z<![CDATA[RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its Chief Financial Officer role. Current CFO Sue Cheung has chosen to resign for personal reasons, effective March 9, 2022. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while the company begins a national search for a permanent CFO.]]>https://www.globenewswire.com/news-release/2022/02/15/2385227/0/en/Marrone-Bio-and-Corteva-Agriscience-Announce-New-Distribution-Contract.html?f=22&fvtc=4&fvtv=19271Marrone Bio and Corteva Agriscience Announce New Distribution Contract2022-02-15T13:00:00Z<![CDATA[The companies build on existing seed treatment partnership to offer novel foliar bionutrient The companies build on existing seed treatment partnership to offer novel foliar bionutrient]]>https://www.globenewswire.com/news-release/2022/01/18/2368479/0/en/Marrone-Bio-Innovations-Issues-Shareholder-Letter.html?f=22&fvtc=4&fvtv=19271Marrone Bio Innovations Issues Shareholder Letter2022-01-18T13:30:00Z<![CDATA[Announces Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results Announces Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results]]>